ClassID:

21256

A61K45/06 - page 37 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#10801
20220226429
2022-07-21

Enteric combination therapy

#10802
20220226404
2022-07-21

Medical compositions with Omega-3 containing excipients

#10803
20220226403
2022-07-21

METHODS OF IMPROVING REPRODUCTIVE AND RESPIRATORY HEALTH

#10804
20220226367
2022-07-21

THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION

#10805
20220226366
2022-07-21

Substituted phenyl boronic acid containing polymers and methods of use

#10806
20220226364
2022-07-21

THERAPEUTIC TARGETS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#10807
20220226360
2022-07-21

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#10808
20220226359
2022-07-21

ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT

#10809
20220226345
2022-07-21

CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE

#10810
20220226337
2022-07-21

COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN

#10811
20220226336
2022-07-21

COMBINATION THERAPY FOR TREATING CANCER

#10812
20220226328
2022-07-21

Heterocyclic compounds, preparation methods and uses thereof

#10813
20220226314
2022-07-21

Benzamide compounds

#10814
20220226310
2022-07-21

Bio-Based Medicines and Methods of Increasing Patient Compliance

#10815
20220226309
2022-07-21

MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE

#10816
20220226307
2022-07-21

INHIBITION OF BETA-2 NICOTINIC ACETYLCHOLINE RECEPTORS TO TREAT ALZHEIMER'S DISEASE PATHOLOGY

#10817
20220226305
2022-07-21

METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME

#10818
20220226298
2022-07-21

GPR40 AGONISTS

#10819
20220226290
2022-07-21

TELMISARTAN FOR THE TREATMENT OF HYPERTENSION IN DOGS

#10820
20220226286
2022-07-21

COMPOSITIONS AND METHODS FOR THE TREATMENT AND MITIGATION OF ALCOHOL-INDUCED SKIN FLUSHING

#10821
20220226281
2022-07-21

COMPOUNDS FOR USE IN ANTI-CANCER IMMUNOTHERAPY

#10822
20220226263
2022-07-21

Composition for Prevention, Amelioration, or Treatment of Cancer

#10823
20220226262
2022-07-21

METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE

#10824
20220226259
2022-07-21

CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLS

#10825
20220226251
2022-07-21

COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS

#10826
20220226240
2022-07-21

ORALLY ADMINISTRABLE COMPOSITION

#10827
20220226223
2022-07-21

Stable silk protein fragment compositions

#10828
20220225660
2022-07-21

POUCHED PRODUCTS WITH HEAT SEALABLE BINDER

#10829
20220220565
2022-07-14

METHODS AND COMPOSITIONS FOR TREATING MELANOMA

#10830
20220220506
2022-07-14

Compositions and processes for targeted delivery, expression and modulation of coding ribonucleic acids in tissue

#10831
20220220484
2022-07-14

METHODS AND COMPOSITIONS OF SHORT SMALL HAIRPIN RNAS AND MICRORNAS FOR WOUND HEALING

#10832
20220220479
2022-07-14

MODULATORS OF TELOMERE DISEASE

#10833
20220220458
2022-07-14

Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy

#10834
20220220223
2022-07-14

Treatment of allergic diseases with chimeric protein

#10835
20220220213
2022-07-14

Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A

#10836
20220220202
2022-07-14

COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF AUTOIMMUNE AND INFLAMMATORY DISEASES

#10837
20220220153
2022-07-14

B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION INHIBITING PEPTIDOMIMETICS

#10838
20220220150
2022-07-14

Compositions and methods for treating CNS disorders

#10839
20220220148
2022-07-14

METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR CONDITIONS RELATED TO THE SAME

#10840
20220220147
2022-07-14

CD73 inhibitors

#10841
20220220126
2022-07-14

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

#10842
20220220122
2022-07-14

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

#10843
20220220101
2022-07-14

Compositions and methods for viral sensitization

#10844
20220220096
2022-07-14

JAK1 SELECTIVE KINASE INHIBITOR

#10845
20220220078
2022-07-14

Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

#10846
20220219015
2022-07-14

METHOD OF TREATMENT BY RADIOTHERAPY

#10847
20220218874
2022-07-14

COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION

#10848
20220218850
2022-07-14

Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents

#10849
20220218828
2022-07-14

TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORINATED ALKANES

#10850
20220218827
2022-07-14

DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES

#10851
20220218823
2022-07-14

Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

#10852
20220218801
2022-07-14

COMBINATION GMCI AND ATRI CANCER TREATMENT

#10853
20220218798
2022-07-14

COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS

#10854
20220218797
2022-07-14

Sequence specific antimicrobials

#10855
20220218796
2022-07-14

Sequence specific antimicrobials

#10856
20220218795
2022-07-14

Sequence specific antimicrobials

#10857
20220218792
2022-07-14

COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS

#10858
20220218789
2022-07-14

Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral Infections

#10859
20220218768
2022-07-14

METHODS OF ENHANCING THE POTENCY OF INCRETIN-BASED DRUGS IN SUBJECTS IN NEED THEREOF

#10860
20220218764
2022-07-14

METHODS FOR IMPROVING TREATMENT OF EQUINE COLIC BY ADMINISTRATION OF A SYNTHETIC BIOENSEMBLE OR PURIFIED STRAINS THEREOF

#10861
20220218758
2022-07-14

QUADRI-POSITIVE STROMAL CELL (QPSC) POPULATION FOR SUPERIOR CELL PROTECTION AND IMMUNOMODULATION

#10862
20220218733
2022-07-14

Therapeutic pharmaceutical composition for cancer including miRNA

#10863
20220218731
2022-07-14

COMBINATION THERAPIES FOR CANCER TREATMENT

#10864
20220218715
2022-07-14

NOVEL USE OF PYRROLO-PYRIDINE DERIVATIVE COMPOUND FOR PREVENTION AND/OR TREATMENT OF CANCER

#10865
20220218705
2022-07-14

COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES

#10866
20220218703
2022-07-14

FGFR INHIBITORS FOR THE TREATMENT OF CANCER

#10867
20220218701
2022-07-14

COMPOSITIONS AND METHODS COMPRISING ENDOTHELIN A RECEPTOR ANTAGONISTS AND ANDROGEN THERAPIES

#10868
20220218697
2022-07-14

Treatment of chronic cough, breathlessness and dyspnea

#10869
20220218677
2022-07-14

ARYLQUINOZILINE DERIVATIVES AS ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA

#10870
20220218671
2022-07-14

TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS

#10871
20220218670
2022-07-14

METHODS OF TREATING DISEASES CHARACTERISED BY VASOCONSTRICTION

#10872
20220218667
2022-07-14

DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND METHODS OF USE THEREOF

#10873
20220218662
2022-07-14

COMBINED MAPK AND NAMPT INHIBITION FOR TREATMENT OF NEURON DEGENERATION

#10874
20220218659
2022-07-14

PI3K/LYN-ACLY Signaling Inhibition

#10875
20220218654
2022-07-14

ANTIBIOTIC CANNABINOID-TERPENE FORMULATIONS

#10876
20220218652
2022-07-14

METHODS OF TREATING CYTOKINE RELEASE SYNDROME

#10877
20220218644
2022-07-14

METHOD AND COMPOSITION FOR TREATING OSTEOARTHRITIS

#10878
20220218641
2022-07-14

METHODS OF TREATMENT WITH DEUTERATED ANALOGS OF D-SERINE

#10879
20220218639
2022-07-14

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

#10880
20220218638
2022-07-14

Sensorineural Hair Cell Differentiation

#10881
20220218635
2022-07-14

Ketone supplements-evoked effect on absence epilepsy by co-administration of uridine

#10882
20220218630
2022-07-14

METHODS AND FORMULATIONS FOR TREATING VISION DISORDERS

#10883
20220218616
2022-07-14

TABLET AND METHOD FOR PRODUCING TABLET

#10884
20220218615
2022-07-14

Synthetic progestogens and pharmaceutical compositions comprising the same

#10885
20220218613
2022-07-14

Treatment of hip pain with sustained-release liposomal anesthetic compositions

#10886
20220218610
2022-07-14

Treatment of hip pain with sustained-release liposomal anesthetic compositions

#10887
20220218608
2022-07-14

INJECTABLE POLYMER NANOPARTICLE COMPOSITIONS OF ANTITHROMBOTIC AGENTS AND METHODS THEREOF

#10888
20220213552
2022-07-07

METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER

#10889
20220213483
2022-07-07

METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

#10890
20220213479
2022-07-07

RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION

#10891
20220213472
2022-07-07

MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS

#10892
20220213440
2022-07-07

DENDRITIC CELL IMMUNOTHERAPY

#10893
20220213233
2022-07-07

CROSSLINKED POLYMER OF FUNCTIONALIZED HYALURONIC ACID AND ITS USE IN THE TREATMENT OF INFLAMMATORY STATES

#10894
20220213223
2022-07-07

Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells

#10895
20220213219
2022-07-07

Bruton's Tyrosine Kinase as Anti-Cancer Drug Target

#10896
20220213210
2022-07-07

COMBINATION THERAPY OF MULTIPLE SCLEROSIS COMPRISING A CD20 LIGAND

#10897
20220213207
2022-07-07

Immunomodulatory antibodies

#10898
20220213201
2022-07-07

ANTI-TIE2 ANTIBODY AND USE THEREOF

#10899
20220213197
2022-07-07

MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES

#10900
20220213168
2022-07-07

Peptides and combination of peptides for use in immunotherapy against various tumors

#10901
20220213137
2022-07-07

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

#10902
20220213126
2022-07-07

SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES

#10903
20220213121
2022-07-07

SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITY

#10904
20220213111
2022-07-07

SUBSTITUTED HETEROCYCLES AS CYCLIC TREX1 INHIBITORS

#10905
20220213106
2022-07-07

Inhibitors of Bruton's Tyrosine Kinase

#10906
20220213078
2022-07-07

MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY

#10907
20220213076
2022-07-07

GHRELIN O-ACYLTRANSFERASE INHIBITORS

#10908
20220213072
2022-07-07

Metabolites of GLP1R agonists

#10909
20220213057
2022-07-07

Oxopiperazine derivatives

#10910
20220213055
2022-07-07

SUBSTITUTED (PIPERIDIN-1-YL)ARYL ANALOGUES FOR MODULATING AVIL ACTIVITY

#10911
20220213047
2022-07-07

CARBONIC ANHYDRASE INHIBITORS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION

#10912
20220213014
2022-07-07

CRYSTALLINE POLYMORPHS OF 1,6-DIBROMO-1,6-DIDEOXY-DULCITOL

#10913
20220211922
2022-07-07

Surgical system and methods of use

#10914
20220211875
2022-07-07

INTRANASAL ADMINISTRATION OF ADENO-ASSOCIATED VIRUS TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS

#10915
20220211853
2022-07-07

Use of fructose in preparing drug for treating ischemic injury

#10916
20220211851
2022-07-07

Pharmaceutical compositions comprising meloxicam

#10917
20220211829
2022-07-07

Methods of cancer treatment using activated t cells

#10918
20220211828
2022-07-07

TARGET PEPTIDES FOR OVARIAN CANCER THERAPY AND DIAGNOSTICS

#10919
20220211824
2022-07-07

METHODS FOR TREATING BREAST AND OTHER CANCERS BY TARGETING ARGININOSUCCINATE SYNTHETASE 1-DEFICIENCY

#10920
20220211820
2022-07-07

Fungal iron acquisition inhibitors and uses thereof

#10921
20220211815
2022-07-07

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#10922
20220211813
2022-07-07

METHODS FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C

#10923
20220211812
2022-07-07

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

#10924
20220211811
2022-07-07

COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF

#10925
20220211810
2022-07-07

Method of Treatment

#10926
20220211809
2022-07-07

TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF

#10927
20220211805
2022-07-07

METHODS FOR TREATING HETEROTOPIC OSSIFICATION

#10928
20220211797
2022-07-07

Inhibitors of IAP

#10929
20220211783
2022-07-07

GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER

#10930
20220211762
2022-07-07

PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT

#10931
20220211741
2022-07-07

METHODS FOR THE TREATMENT AND PROGNOSIS OF CANCER

#10932
20220211736
2022-07-07

Treatments of prostate cancer

#10933
20220211733
2022-07-07

Compositions and products for infectious or inflammatory diseases or conditions

#10934
20220211727
2022-07-07

Mito-magnolol compounds and methods of synthesis and use thereof

#10935
20220211726
2022-07-07

UVEAL MELANOMA TREATMENT

#10936
20220211715
2022-07-07

PHARMACEUTICAL COMBINATION

#10937
20220211710
2022-07-07

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH NUCLEOSIDE-METABOLISM MODULATORS

#10938
20220211706
2022-07-07

Methods and Compositions for Treating Cancer

#10939
20220211702
2022-07-07

METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION

#10940
20220211701
2022-07-07

Treatment of cancer utilizing an identified adenosine fingerprint

#10941
20220211700
2022-07-07

Methods for Objective Assessment of Memory, Early Detection of Risk for Alzheimer's Disease, Matching Individuals With Treatments, Monitoring Response to Treatment, and New Methods of Use for Drugs

#10942
20220211694
2022-07-07

QUINOLINE DERIVATIVES FOR TREATMENT OF HEAD AND NECK CANCER

#10943
20220211693
2022-07-07

QUINOLINE DERIVATIVE USED FOR SOFT TISSUE SARCOMA COMBINATION THERAPY

#10944
20220211690
2022-07-07

METHODS FOR TREATING PTEN-MUTANT TUMORS

#10945
20220211679
2022-07-07

ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS

#10946
20220211676
2022-07-07

COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES

#10947
20220211671
2022-07-07

Injectable psychoactive alkaloid composition and preparation thereof

#10948
20220211670
2022-07-07

PREVENTING AND TREATING MALARIA

#10949
20220211665
2022-07-07

PYRROLE AMIDE COMPOUND AND USE THEREOF

#10950
20220211664
2022-07-07

LYMPH DIRECTING PRODRUGS

#10951
20220211662
2022-07-07

METHOD OF TREATING CANCER BY ADMINISTERING AN EPIGALLOCATECHIN GALLATE COMBINED WITH TYROSINE KINASE INHIBITOR

#10952
20220211659
2022-07-07

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#10953
20220211658
2022-07-07

METHODS FOR TREATING DISORDERS ASSOCIATED WITH SLEEP SPINDLE DEFICITS

#10954
20220211657
2022-07-07

METHODS OF TREATING GASTROINTESTINAL CANCERS AND TUMORS THEREOF USING COMBINATION THERAPY

#10955
20220211656
2022-07-07

Cannabinoid prodrug compounds

#10956
20220211651
2022-07-07

COMPOSITION CONTAINING CREATINE FATTY ESTER FOR USE IN MEDICINE

#10957
20220211649
2022-07-07

Stable aqueous capsaicin injectable formulations and medical uses thereof

#10958
20220211647
2022-07-07

COMPOSITIONS AND METHODS FOR POTENTIATING DERIVATIVES OF 4-AMINOPHENOLS

#10959
20220211645
2022-07-07

Maximizing Distribution and Minimizing Washout of Injectates in Bone and Method for Enhanced Aspirate Extraction

#10960
20220211641
2022-07-07

COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE

#10961
20220211638
2022-07-07

PRODUCTS OF MANUFACTURE AND METHODS FOR TRANSDERMAL DELIVERY OF PHARMACEUTICALS, ELECTROLYTES, AND NUTRICEUTICALS

#10962
20220211620
2022-07-07

Pain Relieving Spray

#10963
20220211619
2022-07-07

Water soluble compositions and methods of making the same

#10964
20220211614
2022-07-07

COMPOSITIONS AND IMPLANTABLE DEVICES

#10965
20220211612
2022-07-07

GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM

#10966
20220205878
2022-06-30

Dirofilaria volatile organic compound signatures and uses thereof

#10967
20220204928
2022-06-30

EXTRACELLULAR VESICLES DERIVED FROM ACTIVATED CAR-T CELLS

#10968
20220204644
2022-06-30

COMBINATION OF HER2 ANTIBODIES

#10969
20220204641
2022-06-30

ANTI-CD20 COMBINATIONS FOR TREATING TUMORS

#10970
20220204640
2022-06-30

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

#10971
20220204637
2022-06-30

ANTI-CD137 MOLECULES AND USE THEREOF

#10972
20220204636
2022-06-30

ANTIBODIES AGAINST HUMAN CD38

#10973
20220204634
2022-06-30

Anti-NPR1 antibodies and uses thereof

#10974
20220204628
2022-06-30

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS

#10975
20220204625
2022-06-30

Combination Therapy for the Treatment of Cancer

#10976
20220204617
2022-06-30

USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE

#10977
20220204605
2022-06-30

CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF USE

#10978
20220204595
2022-06-30

Antibody molecules and uses thereof

#10979
20220204594
2022-06-30

Compositions and methods for the removal of biofilms

#10980
20220204592
2022-06-30

Ha binding agents

#10981
20220204582
2022-06-30

Synthetic immune receptors and methods of use thereof

#10982
20220204572
2022-06-30

TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9

#10983
20220204530
2022-06-30

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

#10984
20220204450
2022-06-30

Orally Active Melanocortin Receptor-4 Compounds

#10985
20220202954
2022-06-30

HIGH-DENSITY AND SHORT-CHAIN PEG MODIFIED NANO-SIZED CARRIERS AND THEIR USES

#10986
20220202945
2022-06-30

METHODS FOR REDUCING TOXICITY OF A CHEMOTHERAPEUTIC DRUG

#10987
20220202933
2022-06-30

Method of treating, reducing, or alleviating a medical condition in a patient

#10988
20220202922
2022-06-30

INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY

#10989
20220202919
2022-06-30

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

#10990
20220202917
2022-06-30

DEPOLYMERASE CAPABLE OF DEGRADING EXTRACELLULAR POLYMERIC SUBSTANCES OF KLEBSIELLA PNEUMONIAE

#10991
20220202915
2022-06-30

SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF

#10992
20220202908
2022-06-30

Therapeutic uses of dulaglutide

#10993
20220202884
2022-06-30

COMPOSITIONS AND METHODS OF USING SENECA VALLEY VIRUS (SVV) FOR TREATING CANCER

#10994
20220202859
2022-06-30

CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

#10995
20220202848
2022-06-30

Therapeutic pharmaceutical composition for cancer including miRNA

#10996
20220202845
2022-06-30

METHODS AND COMPOSITIONS FOR TREATING CANCER

#10997
20220202838
2022-06-30

COMBINATIONAL THERAPIES FOR TREATMENT OF CANCER COMPRISING A BACTERIOCHLOROPHYLL DERIVATIVE

#10998
20220202834
2022-06-30

JAK inhibitor with a vitamin D analog for treatment of skin diseases

#10999
20220202833
2022-06-30

ANTIFUNGAL AGENTS USED IN COMBINATION

#11000
20220202829
2022-06-30

NON-IRRITATING TESTOSTERONE EMULSIONS

#11001
20220202826
2022-06-30

METHODS FOR TREATING GI TRACT DISORDERS

#11002
20220202823
2022-06-30

METHODS FOR PREVENTING TOXICITY OF PLATINUM DRUGS

#11003
20220202822
2022-06-30

8-SUBSTITUTED ARYL VINYL XANTHINE DERIVATIVES AND USES THEREOF

#11004
20220202815
2022-06-30

TREATMENT OF CANCER

#11005
20220202814
2022-06-30

TREATMENT OF CANCER

#11006
20220202811
2022-06-30

TREATMENT FOR RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR Ɣ (RORƔ)-DEPENDENT CANCERS

#11007
20220202809
2022-06-30

METHODS OF TREATING DEPRESSION WITH VORTIOXETINE

#11008
20220202808
2022-06-30

Compositions For Affecting Weight Loss

#11009
20220202806
2022-06-30

TREATMENT OF H-RAS-DRIVEN TUMORS

#11010
20220202802
2022-06-30

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF KIDNEY DISEASES

#11011
20220202798
2022-06-30

USE OF PRIDOPIDINE FOR THE TREATMENT OF FRAGILE X SYNDROME

#11012
20220202794
2022-06-30

Antitumor composition

#11013
20220202792
2022-06-30

METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES

#11014
20220202791
2022-06-30

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS

#11015
20220202790
2022-06-30

Salts of selective estrogen receptor degraders

#11016
20220202789
2022-06-30

ADMINISTRATION OF BERBERINE METABOLITES

#11017
20220202787
2022-06-30

ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF

#11018
20220202785
2022-06-30

Small molecule inhibitors of GPCR GPR68 and related receptors for treating cancer, glioblastoma, and other indications

#11019
20220202772
2022-06-30

COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS

#11020
20220202768
2022-06-30

DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM

#11021
20220202767
2022-06-30

CANNABIS COMPOSITION

#11022
20220202765
2022-06-30

CANNABINOID COMPOSITIONS AND METHODS OF USING

#11023
20220202762
2022-06-30

Benzonatate modified release solid tablets and capsules

#11024
20220202757
2022-06-30

PROTEIN SUBSTITUTE AMINO ACID COMPOSITIONS AND PRODUCTS, AND OTHER FOOD AND BEVERAGE PRODUCTS

#11025
20220202750
2022-06-30

DYE COMPOSITION FOR MARKING ORGANIC TISSUE WITH ANAESTHETIC AND METHOD FOR APPLYING SAME

#11026
20220202746
2022-06-30

Pharmaceutical composition

#11027
20220202744
2022-06-30

METHODS OF TREATING MENTAL DISORDERS

#11028
20220202741
2022-06-30

Methods of treatment of temozolomide-resistant glioma using coenzyme Q10

#11029
20220202738
2022-06-30

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#11030
20220202737
2022-06-30

TREATMENT OF HIDRADENITIS SUPPURATIVA WITH TAPINAROF COMPOSITIONS

#11031
20220196667
2022-06-23

TUMOR MICROBIOME SIGNATURE AND THERAPEUTIC USE OF FECAL MICROBIOTA TRANSPLANTATION ON PANCREATIC CANCER PATIENTS

#11032
20220196652
2022-06-23

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

#11033
20220195534
2022-06-23

METHOD AND KIT FOR DETECTING RISK OF COLORECTAL CANCER

#11034
20220195524
2022-06-23

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND MANAGEMENT OF NEURODEGERATIVE DISEASES

#11035
20220195459
2022-06-23

REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)

#11036
20220195063
2022-06-23

Anti-SIRP α antibodies

#11037
20220195059
2022-06-23

Rank Pathway Inhibitors in Combination with CDK Inhibitors

#11038
20220195054
2022-06-23

Anti-axl antagonistic antibodies

#11039
20220195050
2022-06-23

Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector

#11040
20220195047
2022-06-23

ANTI-PD-1 ANTIBODIES AND USES THEREOF

#11041
20220195027
2022-06-23

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER

#11042
20220195025
2022-06-23

Methods for Treating Osteogenesis Imperfecta

#11043
20220195024
2022-06-23

Monoclonal Antibodies to ELTD1 and Uses Thereof

#11044
20220195010
2022-06-23

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL

#11045
20220194984
2022-06-23

Immunotherapy against several tumors including lung cancer

#11046
20220194964
2022-06-23

SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF

#11047
20220194962
2022-06-23

AZAZINOINDAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

#11048
20220194951
2022-06-23

DIHYDROPYRIMIDINE COMPOUND AND APPLICATION THEREOF AS DRUG

#11049
20220194939
2022-06-23

Novel compounds and methods of use treating fructose-related disorders or diseases

#11050
20220194938
2022-06-23

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

#11051
20220194920
2022-06-23

HETEROARYL(HETEROCYCLYL)METHANOL COMPOUNDS USEFUL IN THE TREATMENT OF HYPERGLYCAEMIA

#11052
20220194849
2022-06-23

Compositions and methods for adhesion to surfaces

#11053
20220193386
2022-06-23

MICRONEEDLE ARRAYS FOR CANCER THERAPY APPLICATIONS

#11054
20220193254
2022-06-23

HYDROGEL FOR IN-VIVO RELEASE OF MEDICATION

#11055
20220193248
2022-06-23

Peptide-linked drug delivery system

#11056
20220193241
2022-06-23

AGENT TARGETING DOUBLE-MEMBRANE ORGANELLE DNA

#11057
20220193234
2022-06-23

METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS

#11058
20220193215
2022-06-23

METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY

#11059
20220193209
2022-06-23

COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS AND/OR TREATING IMMUNODEFICIENCY VIRUS INFECTION

#11060
20220193206
2022-06-23

Methods and compositions for treating coronavirus infections

#11061
20220193197
2022-06-23

SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN

#11062
20220193194
2022-06-23

Method of treating cancer with an immune checkpoint inhibitor in combination with another therapeutic agent

#11063
20220193192
2022-06-23

METHODS OF TREATING A TRAUMATIC BRAIN INJURY

#11064
20220193187
2022-06-23

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

#11065
20220193186
2022-06-23

METHOD OF TREATING AND PREVENTING BONE AND JOINT INFECTIONS

#11066
20220193183
2022-06-23

COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE

#11067
20220193181
2022-06-23

S-NITROSOGLUTATHIONE (GSNO) AND GSNO REDUCATASE INHIBITORS FOR USE IN THERAPY

#11068
20220193158
2022-06-23

Composition for use in the treatment of major depressive disorder

#11069
20220193149
2022-06-23

COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY

#11070
20220193144
2022-06-23

Methods and compositions for modulating angiogenesis and vasculogenesis

#11071
20220193122
2022-06-23

Methods and compositions for treating heart conditions

#11072
20220193121
2022-06-23

Compositions of nitrates and methods of use thereof

#11073
20220193113
2022-06-23

NOVEL THERAPEUTIC AGENT FOR GASTROINTESTINAL CANCER AND METHOD FOR SCREENING FOR THE SAME

#11074
20220193101
2022-06-23

Methods for treating and Pharmaceutical compositions

#11075
20220193096
2022-06-23

INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY

#11076
20220193095
2022-06-23

PHARMACEUTICAL COMPOSITIONS

#11077
20220193089
2022-06-23

Combinations including ABX196 for the treatment of cancer

#11078
20220193087
2022-06-23

COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#11079
20220193082
2022-06-23

COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY

#11080
20220193079
2022-06-23

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#11081
20220193066
2022-06-23

QUINOLINE DERIVATIVE USED FOR COMBINATION TREATMENT OF SMALL CELL LUNG CANCER

#11082
20220193061
2022-06-23

METHOD OF TREATING A SKIN CONDITION

#11083
20220193056
2022-06-23

Compositions and methods of treating PIK3CA helical domain mutant cancers

#11084
20220193053
2022-06-23

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

#11085
20220193032
2022-06-23

Pharmaceutical compositions comprising statins and hyaluronic acid derivatives

#11086
20220193024
2022-06-23

USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA

#11087
20220193020
2022-06-23

Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer

#11088
20220193016
2022-06-23

COMPOSITIONS, METHODS AND USES FOR TARGETING C-TERMINAL BINDING PROTEIN (CtBP) IN TRAUMATIC BRAIN INJURY

#11089
20220193014
2022-06-23

LIPID PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF

#11090
20220193001
2022-06-23

Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement

#11091
20220192995
2022-06-23

COATINGS FOR GASTRIC RESIDENCE DOSAGE FORMS

#11092
20220192993
2022-06-23

DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF

#11093
20220192991
2022-06-23

Synthetic progestogens and pharmaceutical compositions comprising the same

#11094
20220192985
2022-06-23

METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF

#11095
20220192984
2022-06-23

PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS

#11096
20220192973
2022-06-23

Effervescent composition and method of making it

#11097
20220192191
2022-06-23

Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms

#11098
20220187300
2022-06-16

TUMOR CELL-DERIVED MICROVESICLES

#11099
20220185904
2022-06-16

CD20 BINDING SINGLE DOMAIN ANTIBODIES

#11100
20220185900
2022-06-16

HUMAN ANTIBODIES THAT BIND RET AND METHODS OF USE THEREOF